Profound_Logo_CMYK copy.jpg
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’
26 nov. 2024 07h45 HE | Profound Medical Corp.
TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
12 nov. 2024 08h00 HE | Profound Medical Corp.
TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Third Quarter 2024 Financial Results
07 nov. 2024 16h05 HE | Profound Medical Corp.
TORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
04 nov. 2024 06h55 HE | Profound Medical Corp.
– TULSA to stand above all other covered prostate disease treatment modalities at Urology Level 7 reimbursement – – First-time CPT® code reimbursement for TULSA to be effective...
Profound_Logo_CMYK copy.jpg
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
17 oct. 2024 16h30 HE | Profound Medical Corp.
TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
16 oct. 2024 16h15 HE | Profound Medical Corp.
– Mr. Tamberrino and Profound’s CEO, Arun Menawat, previously worked together at NOVADAQ before it was acquired by Stryker in 2017 – – Appointment comes as Profound continues to make final...
Profound_Logo_CMYK copy.jpg
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
16 sept. 2024 08h00 HE | Profound Medical Corp.
- Educational event for physicians by physicians; participants heard from an esteemed panel of experts, innovators, and guest speakers - - Global medtech leaders, Siemens Healthineers and Cook...
Profound_Logo_CMYK copy.jpg
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
04 sept. 2024 16h30 HE | Profound Medical Corp.
TORONTO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Second Quarter 2024 Financial Results
08 août 2024 16h05 HE | Profound Medical Corp.
TORONTO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
18 juil. 2024 16h30 HE | Profound Medical Corp.
TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...